Efficacy and safety of oral iron supplementation with liposomal iron in non-dialysis chronic kidney disease patients with iron deficiency

被引：0
|
作者：
Cesarano, Davide [1 ]
Campilongo, Giorgia [2 ]
Papadia, Federica [2 ]
De Marco, Antonia [2 ]
Borrelli, Silvio [1 ]
Cirillo, Pietro [2 ]
Minutolo, Roberto [1 ]
机构：
[1] Univ Campania Luigi Vanvitelli, Naples, Italy
[2] Univ Bari Aldo Moro, Bari, Italy
来源：
NEPHROLOGY DIALYSIS TRANSPLANTATION | 2024年 / 39卷
关键词：
D O I：
暂无
中图分类号：
R3 [基础医学]; R4 [临床医学];
学科分类号：
1001 ; 1002 ; 100602 ;
摘要：
2264
引用
收藏
页码：I2325 / I2326
页数：2
相关论文
共 50 条
  • [31] Intravenous versus oral iron for treatment of iron deficiency in non-hemodialysis-dependent patients with chronic kidney disease
    Liles, Anne Marie
    AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2012, 69 (14) : 1206 - 1211
  • [32] The FIND-CKD study-a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
    Macdougall, Iain C.
    Bock, Andreas
    Carrera, Fernando
    Eckardt, Kai-Uwe
    Gaillard, Carlo
    Van Wyck, David
    Roubert, Bernard
    Cushway, Timothy
    Roger, Simon D.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2014, 29 (04) : 843 - 850
  • [33] Safety and efficacy of ferric citrate in phosphate reduction and iron supplementation in patients with chronic kidney disease
    Wu, Mei-Yi
    Chen, Ying-Chun
    Lin, Chun-Hung
    Wu, Yun-Chun
    Tu, Yu-Kang
    Tarng, Der-Cherng
    ONCOTARGET, 2017, 8 (63) : 107283 - 107294
  • [34] Comparison of intravenous iron sucrose to oral iron in the treatment of anemic patients with chronic kidney disease not on dialysis
    Charytan, C
    Qunibi, W
    Bailie, GR
    NEPHRON CLINICAL PRACTICE, 2005, 100 (03): : C55 - C62
  • [35] Treatment of Iron Deficiency Anemia With Oral Liposomal Iron in IBD: A Pilot Study Evaluating the Efficacy and Safety
    Antunes, Carla Valeria
    Chebli, Liliana
    Ribeiro, Tarsila
    Malaguti, Carla
    Gaburri, Pedro
    Furtado, Maria Cristina
    Nascimento, Cristiano Rodrigo
    Fava, Lidiane Martins
    Antunes, Priscila
    Correa, Jose Otavio
    dos Santos, Sandra Neves
    Antunes, Tatiane
    Pereira, Yussef
    Freitas, Lucas Manoel
    Costa, Livia
    Chebli, Julio
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 : S5 - S6
  • [36] IS HEPCIDIN-25 A CLINICALLY RELEVANT PARAMETER FOR THE IRON STATUS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE PATIENTS?
    Barsan, Liliana
    Stancu, Simona
    Stancu, Simona
    Stanciu, Ana
    Capusa, Cristina
    Petrescu, Ligia
    Zugravu, Adrian
    Mircescu, Gabriel
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2012, 27 : 139 - 139
  • [37] Iron deficiency and supplementation in heart failure and chronic kidney disease
    Punj, Shweta
    Ghafourian, Kambiz
    Ardehali, Hossein
    MOLECULAR ASPECTS OF MEDICINE, 2020, 75
  • [38] Liposomal iron in moderate chronic kidney disease
    Montagud-Marrahi, Enrique
    Arrizabalaga, Pilar
    Abellana, Rosa
    Poch, Esteban
    NEFROLOGIA, 2020, 40 (04): : 446 - 452
  • [39] Safety aspects of parenteral iron supplementation therapies in patients with chronic kidney disease
    Potthoff, S. A.
    Muench, H. G.
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2013, 138 (24) : 1312 - 1317
  • [40] A randomized trial of iron isomaltoside 1000 versus oral iron in non-dialysis-dependent chronic kidney disease patients with anaemia
    Kalra, Philip A.
    Bhandari, Sunil
    Saxena, Sanjiv
    Agarwal, Dhananjai
    Wirtz, Georg
    Kletzmayr, Josef
    Thomsen, Lars L.
    Coyne, Daniel W.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2016, 31 (04) : 646 - 655
12345